Drugs Made In America Acquisition Corp. SEC filings DMAAR

Drugs Made In America Acquisition Corp. has 80 filings in SEC EDGAR's recent list, going back to Aug 1, 2024. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (material agreement, other events). The company's fiscal year ends on December 31.

Drugs Made In America Acquisition Corp. SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Other events
Oct 21, 2026 Oct 13, 2026
8-K Current report
Material agreement
Sep 14, 2026 Sep 8, 2026
8-K Current report
Material agreement
Jul 20, 2026 Jul 14, 2026
8-K Current report
Material agreement
May 5, 2026 Apr 29, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
May 1, 2026 Apr 27, 2026
8-K Current report
Material agreement
Apr 28, 2026 Apr 22, 2026
8-K Current report
Other events
Apr 8, 2026 Apr 7, 2026
8-K Current report
Material agreement, New debt, Other events
Mar 27, 2026 Mar 23, 2026
8-K Current report
Other events
Mar 6, 2026 Mar 6, 2026
8-K Current report
Officer or director change
Mar 6, 2026 Feb 28, 2026
8-K Current report
Officer or director change
Nov 18, 2025 Oct 8, 2025
8-K Current report
Unregistered share sale, Other events
Feb 25, 2025 Feb 18, 2025
8-K Current report
Other events
Feb 24, 2025 Feb 20, 2025
8-K Current report
Other events
Feb 4, 2025 Jan 29, 2025
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Jan 30, 2025 Jan 27, 2025

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Blank Checks (SIC 6770)
Listed as
DMAA (Nasdaq), DMAAR (Nasdaq), DMAAU (Nasdaq)
Fiscal year ends
December 31
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
2028614

Other Blank Checks companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.